Luzu 1 % is a topical antifungal preparation used to treat superficial fungal infections of the skin. It contains the active ingredient luliconazole at a concentration of one percent. The medication works by binding to fungal cytochrome p450 enzymes, which are essential for the synthesis of ergosterol, a key component of fungal cell membranes. By inhibiting ergosterol production, the drug disrupts the integrity of the fungal membrane, leading to leakage of cellular contents and cell death. This mechanism selectively affects fungal cells while sparing human skin cells, resulting in therapeutic clearance of the infection. The cream is applied directly to the affected area, allowing the drug to act locally and minimize systemic exposure. Treatment typically requires application once daily for several weeks, depending on the severity and response. The overall effect is the reduction of symptoms such as itching, redness, and scaling associated with dermatophyte infections.

Luzu 1 % is a topical antifungal preparation used to treat superficial fungal infections of the skin. The drug belongs to the class of imidazole derivatives and exerts its activity by inhibiting the fungal cytochrome p450 enzyme lanosterol 14 alpha demethylase. This inhibition blocks the conversion of lanosterol to ergosterol, a key component of the fungal cell membrane. The resulting ergosterol deficiency compromises membrane integrity and leads to the death of susceptible fungal cells. Pharmacodynamically the cream produces concentration dependent fungicidal effects on candida and dermatophyte species present on the treated area. Its pharmacological profile shows rapid skin penetration, minimal systemic absorption, and a favorable safety margin when applied as directed. The therapeutic purpose of Luzu 1 % is therefore to eliminate superficial fungal infections while minimizing systemic exposure and adverse effects.

The most frequently observed side effects are mild headache, temporary fatigue, and occasional nausea. Many individuals also report mild dizziness that usually resolves without intervention. Skin reactions such as mild redness or itching can occur at the site of application. Some people experience brief changes in taste perception that do not persist long term. Gastrointestinal discomfort like mild stomach upset may appear but is generally short lived. These effects are typically self limiting and do not require medical treatment.

Common side effects often include mild headache. Some individuals experience temporary nausea. Dizziness can occur after the first few days. Fatigue is reported by many users during adjustment. Insomnia or difficulty sleeping may be encountered. Dry mouth is another frequently cited reaction.